随着Lehan收购的完成，有望提振前景

2025-07-02 21:14

Home healthcare solutions provider Viemed Healthcare (NASDAQ:VMD) on Wednesday announced plans to increase its 2025 guidance range to reflect contributions from its recently completed acquisition, Lehan's Medical Equipment.
In May, the Lafayette, Louisiana-based company announced an agreement to acquire Lehan's, an Illinois-based healthcare provider, for a $26M base purchase price and contingent payments estimated to be worth $2.2M.
Announcing the completion of the agreement, Viemed (NASDAQ:VMD) said that at the time of its next financial results, it intends to increase its previously revised 2025 guidance of $256M - $265M of revenue and $55M - $58M of adjusted EBITDA to account for the acquisition.
A medical equipment provider focused on women’s health, Lehan’s recorded nearly $25.7M in net revenue and about $7.4M in adjusted EBITDA last year.

More on Viemed Healthcare